Tepotinib is the world’s first highly selective MET inhibitor, playing a crucial role in treating non‑small cell lung cancer (NSCLC) with MET exon 14 skipping mutations.
Latest 2026 Price of Tepotinib
The Laos Big Bear version of tepotinib has a specification of 225mg*60 tablets per box, priced at approximately 936 US dollars per box.Price information is for reference only; actual purchase prices may fluctuate. It is recommended to purchase through formal channels and keep complete purchase vouchers.
Tepotinib Medication Guide
Standardized administration is critical for maximizing the efficacy of tepotinib; the following guidelines are for patient reference.
Correct Administration Method
Take 450mg (2 tablets of 225mg) orally once daily at a fixed time, with food to improve bioavailability. Swallow the tablets whole; do not break, crush, or chew them. Setting a medication reminder helps establish a regular dosing routine.
Adverse Reaction Management
Common edema can be relieved by elevating the limbs and restricting sodium intake. Patients with diarrhea should pay attention to fluid replacement and use antidiarrheal agents if necessary. Seek immediate medical attention if dyspnea or persistent fever occurs.
Efficacy Monitoring
Imaging evaluations should be performed every 8–12 weeks after treatment initiation. Simultaneously monitor changes in tumor markers. It is recommended to record symptom improvements and provide detailed feedback to the doctor during follow‑up visits.Maintain close communication with the attending physician during treatment to adjust the therapeutic regimen promptly. Do not increase or decrease the dose or change the dosing frequency without authorization.
Contraindicated Populations of Tepotinib
Specific populations may face higher risks when using tepotinib and require special attention.
Absolute Contraindications
Severe hepatic impairment (Child‑Pugh class C) is strictly prohibited.
Patients with hypersensitivity to tepotinib or its excipients are contraindicated.
Use during pregnancy may cause fetal malformations; strict contraception is mandatory.
Relative Contraindications
Patients with moderate hepatic impairment require dose reduction.
Patients with a history of interstitial lung disease (ILD) should be treated under close monitoring.
Patients with QT interval prolongation require regular electrocardiographic examinations.
Elderly patients aged 65 years and above need enhanced medication monitoring.
Drug Interaction Contraindications
Avoid concomitant use with strong CYP3A4 inhibitors (e.g., ketoconazole) or inducers (e.g., rifampicin). Grapefruit and its products may affect efficacy and should be avoided during treatment.Before treatment, truthfully inform the doctor of your health status and medication history. Discontinue the drug immediately and seek medical attention if severe adverse reactions occur.
